These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26961482)

  • 1. Editorial: Special Thematic Issuue: Development of Biomarkers in Tumors of Digestive System Part I.
    Zhi Q
    Anticancer Agents Med Chem; 2016; 16(4):406. PubMed ID: 26961482
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial (Thematic Issue: Development of Biomarkers in Tumors of Digestive System Part II).
    Zhi Q
    Anticancer Agents Med Chem; 2016; 16(9):1078. PubMed ID: 27554129
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Diagnostics, Pathology and Biomarkers of Gastrointestinal Neoplasms.
    Gurzu S
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "OMICS" technologies and their role in foregut primary malignancies.
    Farid SG; Morris-Stiff G
    Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of TROP2 in cancer and as potential therapeutic target].
    Huang HY
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):860-3. PubMed ID: 24507116
    [No Abstract]   [Full Text] [Related]  

  • 7. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
    Liu FT; Dong Q; Gao H; Zhu ZM
    Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances on EZH2 in malignant tumors].
    Li J; Fan QH
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):856-8. PubMed ID: 20193471
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Molecular Profiling to Guide Treatment Decisions in Patients with Neuroendocrine Tumors: Preliminary Results.
    Cutler HS; Ogando P; Uhr JH; Gonzalez DO; Warner RR; Divino CM
    Am Surg; 2016 Apr; 82(4):369-75. PubMed ID: 27097632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Non-Coding RNAs as Biomarkers in Tumors of Digestive System.
    Xu Z; Zhi Q
    Anticancer Agents Med Chem; 2019; 19(2):143-144. PubMed ID: 31298143
    [No Abstract]   [Full Text] [Related]  

  • 11. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
    Wu J; Hu L; Wu F; Zou L; He T
    Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P53 tumor suppressor gene in digestive neoplasms].
    Roa JC; Roa I; Araya JC; Villaseca MA; Melo A; Burgos L
    Rev Med Chil; 2000 Nov; 128(11):1269-78. PubMed ID: 11347516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncologic markers in the diagnosis of malignant tumors of the digestive tract].
    Maĭstrenko NA; Kurygin AA; Khrykov GN
    Vestn Khir Im I I Grek; 2002; 161(4):102-6. PubMed ID: 12577567
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of CD133 in neuroendocrine neoplasms of the digestive tract: a detailed immunohistochemical analysis.
    Mia-Jan K; Munkhdelger J; Lee MR; Ji SY; Kang TY; Choi E; Cho MY
    Tohoku J Exp Med; 2013 Apr; 229(4):301-9. PubMed ID: 23615455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reg proteins and their roles in inflammation and cancer of the human digestive system.
    Zhao J; Wang J; Wang H; Lai M
    Adv Clin Chem; 2013; 61():153-73. PubMed ID: 24015602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of HOTAIR for predicting clinical outcome in patients with digestive system tumors.
    Ma G; Wang Q; Lv C; Qiang F; Hua Q; Chu H; Du M; Tong N; Jiang Y; Wang M; Zhang Z; Wang J; Gong W
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2139-45. PubMed ID: 25968902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
    Delektorskaia VV; Kushliskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic pitfalls in digestive neuroendocrine tumours.
    Borbath I; Jamar F; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Peeters M; Roeyen G; Van Cutsem E; Van Hootegem P; Van Laethem JL; Verslype C; Pauwels S
    Acta Gastroenterol Belg; 2009; 72(1):29-33. PubMed ID: 19402368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular cytogenetic analysis of cancer of the digestive system and its clinical application].
    Sasaki K
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():94-9. PubMed ID: 12577938
    [No Abstract]   [Full Text] [Related]  

  • 20. CD44 as a marker in human cancers.
    Sy MS; Mori H; Liu D
    Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.